UK consultation on PGD (pre-implantation genetic diagnosis) moves forward:
This article was originally published in Clinica
The next step in the UK's parliamentary consultation on pre-implantation genetic diagnosis (PGD) will be its fifth oral evidence session, on September 8. The House of Commons Science and Technology Committee will take evidence from seven experts, including: Linda Ball, Muscular Dystrophy Association; Peter and Fiona Hingston, Cystic Fibrosis Trust; Dr Simon Fishel, director of Centres for Assisted Reproduction (CARE); Professor Peter Braude, of Guys, Kings and St Thomas' School of Medicine; and Professor Tom Baldwin, chairman of the Ethics & Law Committee of the HFEA.
You may also be interested in...
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.